← Back to Search

Behavioral Intervention

Text-Based Smoking Cessation Program for Rural Cancer Survivors

Phase 3
Recruiting
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >= 18 years
In order to complete the mandatory patient-completed measures, participants must be able to speak and read English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6-months post-quit date
Awards & highlights

Study Summary

This trial is testing whether a text-based quitting program can help rural cancer patients who smoke, quit smoking. The program gradually reduces the amount of cigarettes smoked, with the goal of quitting altogether.

Who is the study for?
This trial is for rural cancer survivors who currently smoke at least 5 cigarettes daily, have had a cancer diagnosis within the last decade, and may still be undergoing treatment. Participants must be adults with texting-capable phones, not using smoking cessation drugs or programs, able to read English, and willing to provide a urine sample.Check my eligibility
What is being tested?
The study compares a text-based program designed to help smokers quit by gradually reducing cigarette use against traditional methods like manuals. The goal is to see if scheduled texts can more effectively lead participants to stop smoking entirely.See study design
What are the potential side effects?
Since this trial involves educational and informational interventions rather than medications, there are no direct medical side effects. However, participants might experience typical nicotine withdrawal symptoms such as irritability, cravings, or difficulty concentrating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can speak and read English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months post-quit date
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months post-quit date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemically validated tobacco cessation
Secondary outcome measures
Serially measured overall quality of life (QoL) scores obtained at baseline and at 30-days and 6-months post-quite date

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (SGR program, text messages)Experimental Treatment3 Interventions
Patients participate in schedule gradual reduction program over 8 weeks to reduce the frequency of cigarette use. Patients also receive cessation support messages via text messages for 12 weeks.
Group II: Group II (booklet)Active Control1 Intervention
Patients receive NCI's Clearing the Air booklet to help plan to gradually quit smoking.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention
2005
N/A
~1800

Find a Location

Who is running the clinical trial?

Alliance for Clinical Trials in OncologyLead Sponsor
512 Previous Clinical Trials
217,038 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,254 Total Patients Enrolled
Devon Noonan, PhD, MPH, FNP-BCStudy ChairDuke School of Nursing

Media Library

Text-Based Cessation Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05008848 — Phase 3
Cancer Research Study Groups: Group I (SGR program, text messages), Group II (booklet)
Cancer Clinical Trial 2023: Text-Based Cessation Intervention Highlights & Side Effects. Trial Name: NCT05008848 — Phase 3
Text-Based Cessation Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05008848 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study being conducted in more than one location within the city limits?

"The Carle Foundation Hospital in Urbana, Illinois, Spectrum Health Reed City Hospital in Reed City, Michigan, and Illinois CancerCare-Galesburg in Galesburg, Iowa are 3 of the 92 locations where this trial is recruiting patients."

Answered by AI

Are recruitment efforts for this clinical trial still underway?

"Recruitment for this clinical trial is ongoing, as seen on clinicaltrials.gov. The listing was first posted December 1st, 2021 and updated August 2nd, 2022."

Answered by AI

How many people are being helped by this experiment?

"In order to gain the desired data, this clinical trial requires 600 participants that meet specific inclusion criteria. Patients can go to The Carle Foundation Hospital in Urbana, Illinois or Spectrum Health Reed City Hospital in Reed City, Michigan to take part."

Answered by AI

What is the official government stance on this method for quitting smoking?

"There is some evidence to support the efficacy of this smoking cessation intervention, as well as data from multiple rounds of testing that attest to its safety. For these reasons, our team at Power has rated the safety of this intervention a 3."

Answered by AI

Who else is applying?

What state do they live in?
Texas
Michigan
Illinois
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
What site did they apply to?
Saint Joseph London
Novant Health Cancer Institute - Thomasville

Why did patients apply to this trial?

I want to quit Smoking. I've already got COPD.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
2022. "Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05008848.
All > Paid Studies Wyoming
~205 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top